血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白
Recombinant Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 編號(hào)RPA145Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量14.3kDa
- 實(shí)際分子量15kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Ala108~Arg223 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)8.6
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1008¥ 2520¥ 5040¥ 15120¥ 37800
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. Gene Sequencing (Extract)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA145Mu01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA145Mu61 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA145Mu01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA145Mu02 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA145Mu81 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAA145Mu71 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA145Mu21 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體 | WB |
| LAA145Mu72 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA145Mu | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| MEA145Mu | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA145Mu | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA145Mu01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA145Mu01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma[PubMed: 19241443] |
| genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages[PubMed: 26125824] |
| Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia[PubMed: 26622498] |
| Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages[PubMed: 26608451] |
| PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.[pubmed:27383632] |
| Oncology?Letters | RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo.[pubmed:27895746] |
| Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering[Pubmed:29582235] |
| Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells[Pubmed:29328465] |
| LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease[Pubmed: 31019289] |
| Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions?[Pubmed: 32722957] |